Rockville, Maryland – Senseonics Holdings, Inc. recently held its Q3 2024 Earnings Conference Call, where key company executives discussed the financial performance and future outlook. The call took place on November 7, 2024, at 4:30 PM ET.

During the conference call, Tim Goodnow, the President and Chief Executive Officer of Senseonics, along with Rick Sullivan, the Chief Financial Officer, and Brian Hansen, the President of CGM at Ascensia Diabetes Care, shared insights into the company’s recent achievements and upcoming plans.

Analysts and investors, including Brian Langan from Morgan Stanley and Vernon Bernardino from H.C. Wainwright, participated in the call to gain a deeper understanding of Senseonics’ financial standing and strategic direction.

The call was moderated by Jeremy Feffer from LifeSci Advisors, who reminded participants that the company’s statements contained forward-looking information that is subject to certain risks and uncertainties. He encouraged listeners to refer to the company’s regulatory filings for a comprehensive understanding of these factors.

Senseonics reaffirmed its commitment to transparency and accountability by allowing for a question-and-answer session at the end of the call, providing stakeholders with the opportunity to engage directly with company leadership.

Investors and analysts were encouraged to visit Senseonics’ website for additional information on the company’s performance and strategic initiatives, underlining the company’s commitment to open communication and disclosure.

Overall, the Q3 2024 Earnings Conference Call provided a valuable platform for Senseonics to update stakeholders on its progress, address any concerns, and outline its vision for the future in the diabetes care industry.